OrganoClick: Last quarter of tough comps in NW&FT - ABG
Detta är en aktieanalys producerad av tredje part och reflekterar därför nödvändigtvis ej våra åsikter och värderingar
Report out 6 May
Q1e: sales SEK 39m, +2% y-o-y, EBIT SEK 0.5m (0.2m)
Optimistic on GC&MP, cautious on FW & NW&FT
Q1 expectations
For Q1, we estimate sales of SEK 39m, up 1.5% y-o-y, marking a return to growth after four quarters of decline. We expect the growth driver to be the GC&MP segment, which we expect will hold its own (we estimate +15% y-o-y). We estimate NW&FT sales of SEK 11m, -13% y-o-y. However, it is important to note that NW&FT witnessed price decreases in Q2'24, therefore comps this quarter will be based on a higher price component and comps will be easier from Q2. For FW, we expect a stable quarter (+1% y-o-y) due to a continued sluggish construction market. On EBIT, we estimate SEK 0.5m (0.2m).
Q1e: sales SEK 39m, +2% y-o-y, EBIT SEK 0.5m (0.2m)
Optimistic on GC&MP, cautious on FW & NW&FT
Q1 expectations
For Q1, we estimate sales of SEK 39m, up 1.5% y-o-y, marking a return to growth after four quarters of decline. We expect the growth driver to be the GC&MP segment, which we expect will hold its own (we estimate +15% y-o-y). We estimate NW&FT sales of SEK 11m, -13% y-o-y. However, it is important to note that NW&FT witnessed price decreases in Q2'24, therefore comps this quarter will be based on a higher price component and comps will be easier from Q2. For FW, we expect a stable quarter (+1% y-o-y) due to a continued sluggish construction market. On EBIT, we estimate SEK 0.5m (0.2m).